Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Tumor Biomarker Test Market by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM3249922
    • |
  • 03 April, 2019
    • |
  • Global
    • |
  • 115 Pages
    • |
  • XYZResearch
    • |
  • Medical Devices & Consumables

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Tumor Biomarker Test in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Tumor Biomarker Test market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Tumor Biomarker Test for each application, including
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    Global Tumor Biomarker Test Market by Manufacturers, Regions, Type and Application, Forecast to 2023

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Tumor Biomarker Test Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Product Type Market

      • 2.1 World Product Type Market Performance and Trend
        • 2.1.1 World Market Performance
        • 2.1.2 Different Type of Market Performance
      • 2.2 North America Product Type Market Performance and Trend
        • 2.2.1 North America Market Performance
        • 2.2.2 Different Type of Market Performance
      • 2.3 Europe Product Type Market Performance and Trend
        • 2.3.1 Europe Market Performance
        • 2.3.2 Different Type of Market Performance
      • 2.4 Asia-Pacific Product Type Market Performance and Trend
        • 2.4.1 Asia-Pacific Market Performance
        • 2.4.2 Different Type of Market Performance
      • 2.5 South America Product Type Market Performance and Trend
        • 2.5.1 South America Market Performance
        • 2.5.2 Different Type of Market Performance
      • 2.6 Middle East and Africa Product Type Market Performance and Trend
        • 2.6.1 Middle East and Africa Market Performance
        • 2.6.2 Different Type of Market Performance

      3 Product Application Market

      • 3.1 World Product Application Market Performance and Trend
        • 3.1.1 World Market Performance
        • 3.1.2 Different Applications of Market Trend
      • 3.2 North America Product Application Market Performance and Trend
        • 3.2.1 North America Market Performance
        • 3.2.2 Different Applications of Market Trend
      • 3.3 Europe Product Application Market Performance and Trend
        • 3.3.1 Europe Market Performance
        • 3.3.2 Different Applications of Market Trend
      • 3.4 Asia-Pacific Product Application Market Performance and Trend
        • 3.4.1 Asia-Pacific Market Performance
        • 3.4.2 Different Applications of Market Trend
      • 3.5 South America Product Application Market Performance and Trend
        • 3.5.1 South America Market Performance
        • 3.5.2 Different Applications of Market Trend
      • 3.6 Middle East and Africa Product Application Market Performance and Trend
        • 3.6.1 Middle East and Africa Market Performance
        • 3.6.2 Different Applications of Market Trend

      4 Manufacturers Profiles/Analysis

      • 4.1 Abbott Laboratories, Inc.
        • 4.1.1 Abbott Laboratories, Inc. Profiles
        • 4.1.2 Abbott Laboratories, Inc. Product Information
        • 4.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Business Performance
        • 4.1.4 Abbott Laboratories, Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.2 Agilent Technologies
        • 4.2.1 Agilent Technologies Profiles
        • 4.2.2 Agilent Technologies Product Information
        • 4.2.3 Agilent Technologies Tumor Biomarker Test Business Performance
        • 4.2.4 Agilent Technologies Tumor Biomarker Test Business Development and Market Status
      • 4.3 AstraZeneca
        • 4.3.1 AstraZeneca Profiles
        • 4.3.2 AstraZeneca Product Information
        • 4.3.3 AstraZeneca Tumor Biomarker Test Business Performance
        • 4.3.4 AstraZeneca Tumor Biomarker Test Business Development and Market Status
      • 4.4 Becton Dickinson & Co.
        • 4.4.1 Becton Dickinson & Co. Profiles
        • 4.4.2 Becton Dickinson & Co. Product Information
        • 4.4.3 Becton Dickinson & Co. Tumor Biomarker Test Business Performance
        • 4.4.4 Becton Dickinson & Co. Tumor Biomarker Test Business Development and Market Status
      • 4.5 Biocept Inc.
        • 4.5.1 Biocept Inc. Profiles
        • 4.5.2 Biocept Inc. Product Information
        • 4.5.3 Biocept Inc. Tumor Biomarker Test Business Performance
        • 4.5.4 Biocept Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.6 Cancer Genetics Inc.
        • 4.6.1 Cancer Genetics Inc. Profiles
        • 4.6.2 Cancer Genetics Inc. Product Information
        • 4.6.3 Cancer Genetics Inc. Tumor Biomarker Test Business Performance
        • 4.6.4 Cancer Genetics Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.7 Danaher Corporation
        • 4.7.1 Danaher Corporation Profiles
        • 4.7.2 Danaher Corporation Product Information
        • 4.7.3 Danaher Corporation Tumor Biomarker Test Business Performance
        • 4.7.4 Danaher Corporation Tumor Biomarker Test Business Development and Market Status
      • 4.8 Foundation Medicine Inc.
        • 4.8.1 Foundation Medicine Inc. Profiles
        • 4.8.2 Foundation Medicine Inc. Product Information
        • 4.8.3 Foundation Medicine Inc. Tumor Biomarker Test Business Performance
        • 4.8.4 Foundation Medicine Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.9 Illumina Inc.
        • 4.9.1 Illumina Inc. Profiles
        • 4.9.2 Illumina Inc. Product Information
        • 4.9.3 Illumina Inc. Tumor Biomarker Test Business Performance
        • 4.9.4 Illumina Inc. Tumor Biomarker Test Business Development and Market Status
      • 4.10 LabCorp Of America Holdings
        • 4.10.1 LabCorp Of America Holdings Profiles
        • 4.10.2 LabCorp Of America Holdings Product Information
        • 4.10.3 LabCorp Of America Holdings Tumor Biomarker Test Business Performance
        • 4.10.4 LabCorp Of America Holdings Tumor Biomarker Test Business Development and Market Status
      • 4.11 Luminex Corporation
      • 4.12 Myriad Genetics Inc.
      • 4.13 AstraZeneca

      5 Market Performance for Manufacturers

      • 5.1 Global Tumor Biomarker Test Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Tumor Biomarker Test Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
      • 5.4 Global Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
      • 5.5 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 North America Market Performance for Manufacturers
        • 6.1.1 North America Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 North America Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 North America Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 North America Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 Europe Market Performance for Manufacturers
        • 6.2.1 Europe Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 Europe Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 Europe Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 Europe Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Asia-Pacific Market Performance for Manufacturers
        • 6.3.1 Asia-Pacific Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Asia-Pacific Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Asia-Pacific Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Asia-Pacific Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 South America Market Performance for Manufacturers
        • 6.4.1 South America Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 South America Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 South America Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 South America Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Middle East and Africa Market Performance for Manufacturers
        • 6.5.1 Middle East and Africa Tumor Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Middle East and Africa Tumor Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Middle East and Africa Tumor Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Middle East and Africa Tumor Biomarker Test Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration

      7 World Market Performance Point

      • 7.1 World Tumor Biomarker Test Sales (K Units) and Share by Regions and Countries 2013-2018
        • 7.1.1 World Tumor Biomarker Test Sales (K Units) and Share by Regions 2013-2018
        • 7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.1 Asia-Pacific Tumor Biomarker Test Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.2 North America Tumor Biomarker Test Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.3 Europe Tumor Biomarker Test Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.4 South America Tumor Biomarker Test Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.5 Middle East and Africa Tumor Biomarker Test Sales (K Units) and Share by Countries 2013-2018
      • 7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
        • 7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
        • 7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.1 Asia-Pacific Tumor Biomarker Test Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.2 North America Tumor Biomarker Test Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.3 Europe Tumor Biomarker Test Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.4 South America Tumor Biomarker Test Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.5 Middle East and Africa Tumor Biomarker Test Revenue (M USD) and Share by Countries 2013-2018
      • 7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
        • 7.3.1 World Price (USD/Unit) by Regions 2013-2018
        • 7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.1 Asia-Pacific Tumor Biomarker Test Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.2 North America Tumor Biomarker Test Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.3 Europe Tumor Biomarker Test Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.4 South America Tumor Biomarker Test Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.5 Middle East and Africa Tumor Biomarker Test Price (USD/Unit) by Countries 2013-2018
      • 7.4 World Gross Margin by Regions and Countries 2013-2018
        • 7.4.1 World Gross Margin by Regions 2013-2018
        • 7.4.2 Regional Gross Margin and Share by Countries 2013-2018
          • 7.4.2.1 Asia-Pacific Tumor Biomarker Test Gross Margin and Share by Countries 2013-2018
          • 7.4.2.2 North America Tumor Biomarker Test Gross Margin and Share by Countries 2013-2018
          • 7.4.2.3 Europe Tumor Biomarker Test Gross Margin and Share by Countries 2013-2018
          • 7.4.2.4 South America Tumor Biomarker Test Gross Margin and Share by Countries 2013-2018
          • 7.4.2.5 Middle East and Africa Tumor Biomarker Test Gross Margin and Share by Countries 2013-2018

        8 Development Trend for Regions and Countries (Sales Point)

        • 8.1 World Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.3 North America Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.4 Europe Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.5 South America Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.6 Middle East and Africa Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018

        9 Upstream Source, Technology and Cost

        • 9.1 Upstream Source
        • 9.2 Technology
        • 9.3 Cost

        10 Channel Analysis

        • 10.1 Market Channel
        • 10.2 Distributors

        11 Consumer Analysis

        • 11.1 Lung cancer Industry
        • 11.2 Breast cancer Industry
        • 11.3 Colorectal Industry

        12 Market Forecast 2019-2024

        • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
          • 12.1.1 Global Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
          • 12.1.2 Global Tumor Biomarker Test Sales (K Units) and Growth Rate 2019-2024
          • 12.1.3 Asia-Pacific Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.4 Asia-Pacific Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.5 Europe Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.6 South America Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.7 Middle East and Africa Tumor Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
          • 12.2.1 Overall Market Performance
          • 12.2.2 Prostate Specific Antigen Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.3 CTC Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.4 Alpha-Fetoprotein (AFP) Tests Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.5 CA Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.3 Sales by Application 2019-2024
          • 12.3.1 Overall Market Performance
          • 12.3.2 Lung cancer Sales and and Growth Rate 2019-2024
          • 12.3.3 Breast cancer Sales and and Growth Rate 2019-2024
          • 12.3.4 Colorectal Sales and and Growth Rate 2019-2024
          • 12.3.5 Prostate Cancer Sales and and Growth Rate 2019-2024
        • 12.4 Price (USD/Unit) and Gross Profit
          • 12.4.1 Global Tumor Biomarker Test Price (USD/Unit) Trend 2019-2024
          • 12.4.2 Global Tumor Biomarker Test Gross Profit Trend 2019-2024

        13 Conclusion

      Summary:
      Get latest Market Research Reports on Tumor Biomarker Test. Industry analysis & Market Report on Tumor Biomarker Test is a syndicated market report, published as Global Tumor Biomarker Test Market by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Tumor Biomarker Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,150.00
      		$6,200.00
      		2,434.95
      		4,792.60
      		2,932.65
      		5,772.20
      		480,973.50
      		946,678.00
      		265,860.00
      		523,280.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo